Search / 185 results found

from
to
  • Updated

LEBANON, N.H., Oct. 14, 2021 /PRNewswire/ -- Journey Biosciences, Inc., a biotechnology company with an innovative proactive diagnostic screening technology for high risk kidney complications, including Diabetic Kidney Disease (DKD), today announced a collaboration with Cardinal Health (NYSE: CAH) OptiFreight® Logistics that will increase control and visibility across every transportation modality. The collaboration will deliver Journey Biosciences' critical, first-of-its-kind NaviDKD medical diagnostics screening technology to the point-of-care where innovative testing and risk evaluation takes place using cutting-edge proprietary algorithms, which will enable healthcare providers to more proactively diagnose and manage long-term complications associated with diabetes.

  • Updated

MANCHESTER, N.H., Oct. 13, 2021 /PRNewswire/ -- As reported Monday by the Wall Street Journal, an impressive mansion on 88 acres in southern New Hampshire will be sold at a luxury auction scheduled for this Friday, October 15, 2021. Friday's auction will be held without reserve, meaning the highest bidder will become the new property owner regardless of the high bid amount. Prior to hitting the luxury auction block, the property had never before been listed for sale.

HOOKSETT, N.H., Oct. 13, 2021 /PRNewswire/ -- Merchants Fleet ("the Company"), the nation's fastest growing fleet management company, today announced a major expansion of its core member funding group to include some of the top banks in the world, enabling the Company to access $2 billion of capacity to lease vehicles and equipment for clients as well as invest in continued growth. The new group of banks and investors is led by French international banking group BNP Paribas who along with Merchants' lead equity partner Bain Capital Credit, represents over $20 Trillion in assets.

  • Updated

PORTSMOUTH, N.H., Oct. 13, 2021 /PRNewswire/ -- Laborie Medical Technologies Corp. (Laborie) a specialist medical technology company, announced today that it has acquired Pelvalon, Inc., a privately held medical device company located in Redwood City, CA.

  • Updated

BEDFORD, N.H., Oct. 11, 2021 /PRNewswire/ -- LSNE Contract Manufacturing, a leading global contract development and manufacturing organization (CDMO), today announces it has doubled its sterile drug product lyophilization capacity at its Madison, Wisconsin parenteral manufacturing facility, with the installation of a new lyophilizer. The Madison capacity increase is one step in a strategic company-wide lyophilization expansion plan adding capacity to all existing facilities.